Colorectal Cancer | Tumor

CURE’s colorectal cancer page is an extensive resource of cancer information featuring the latest colorectal cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on colorectal cancer.

Can Journaling Help Heal After a Cancer Diagnosis?

July 31st 2025, 4:00pm

Article

Writing helped me focus on gratitude and healing after my colon cancer diagnosis, transforming the act into a powerful recovery tool.

Leronlimab Shows Activity in Advanced Metastatic Colorectal Cancer

July 1st 2025, 4:00pm

Article

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

Zanzalintinib Combo Improves Survival in Metastatic Colorectal Cancer

June 25th 2025, 3:00pm

Article

Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic colorectal cancer, phase 3 data show.

Tecentriq Plus Chemo Reduced Risk of Death vs Chemo Alone in dMMR Colon Cancer

June 1st 2025, 12:00pm

Article

Tecentriq and chemotherapy combination reduces the risk of death versus chemotherapy alone in deficient mismatch repair, stage 3 colorectal cancer.

Braftovi and Erbitux Plus Chemo Improves Outcomes for BRAF V600E+ mCRC

May 30th 2025, 12:00pm

Article

Braftovi and Erbitux plus chemotherapy improved survival without progression over standard therapy in BRAF V600E-mutant mCRC in the first-line setting.

Acoustic Cluster Therapy Shows Benefit in Colorectal Liver Metastases

May 20th 2025, 4:00pm

Article

Tumors shrank more with the addition of acoustic cluster therapy to chemotherapy in colorectal liver metastases in the phase 1 ACTIVATE trial.

Reflecting on my Son's Graduation as a Previvor

May 19th 2025, 5:00pm

Article

As a Lynch syndrome previvor, I feel deep gratitude to witness my son’s graduation — a milestone my brother never lived to see with his own child.

Delving Into the Braftovi Plus Erbitux FDA Approval for BRAF+ mCRC

May 6th 2025, 1:00pm

Article

Dr. Cathy Eng discusses data that led to the FDA approval of Braftovi and Erbitux plus chemo for metastatic colorectal cancer with a BRAF V600E mutation.

Dr. Eng Breaks Down Braftovi Plus Erbitux FDA Approval in BRAF+ mCRC

May 3rd 2025, 6:00pm

Video

Dr. Cathy Eng discusses the importance of the Braftovi plus Erbitux FDA approval for treatment-naive BRAF V600E+ metastatic colorectal cancer.

Recapping Every FDA Approval Announced in April for Cancer Care

May 1st 2025, 9:00pm

Article

Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types.